Format

Send to

Choose Destination
Pancreas. 2001 Oct;23(3):246-50.

Expression of p57/Kip2 protein in pancreatic adenocarcinoma.

Author information

1
Department of Surgery, Osaka Seamen's Insurance Hospital, Osaka, Japan.

Abstract

INTRODUCTION:

Evaluation of the biologic character of carcinomas requires understanding of cell cycle regulators.

AIMS:

To investigate p57 expression in human pancreatic adenocarcinoma and cyst adenoma.

METHODOLOGY:

We examined the expression of p57(Kip2), a member of the Cip/Kip family, in 45 pancreatic adenocarcinomas, 7 cystadenomas, and 7 chronic pancreatitis cases.

RESULTS:

The p57 labeling index (LI) in duct epithelia in chronic pancreatitis averaged 32.8+/-8.3 and was significantly higher than in normal duct epithelia (18.8+/-6.6; p = 0.0011). For the carcinoma, the LI averaged 46.0+/-20.9, which was significantly higher than that for normal duct epithelia (p < 0.0001) and cystadenoma (16.0 11.2; p = 0.0007). However, it was significantly reduced in cases with stage IV disease (p = 0.0351), lymph node metastasis (p = 0.0003), larger size (p = 0.0094), capsular invasion (p = 0.0462), lymphatic invasion (p = 0.0351), and cell proliferating activity (p = 0.0002). In multivariate analysis, p57 LI in pancreatic adenocarcinoma was independently linked to high proliferating activity (p = 0.0230).

CONCLUSION:

These results suggest that p57 plays a role in the hyperplastic change of the ducts in chronic pancreatitis and that pS7 overexpression contributes to the downregulation of cell proliferation, and its decreased expression contributes to the progression of pancreatic adenocarcinoma.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center